急性肺栓塞溶栓治疗的利用与结局:全国性队列研究
该研究分析2016年全国再入院数据库中5436例急性肺栓塞溶栓住院成人,比较全身溶栓与导管定向溶栓(CDT)的使用模式及结局。全身溶栓使用3376例(62.1%),CDT使用2060例(37.9%);全身溶栓组血管升压药使用(4.3% vs 1.0%)、休克(15.8% vs 6.9%)、心脏骤停(12.7% vs 3.4%)和机械通气(19.0% vs 5.9%)比例更高。CDT患者中417例(20.2%)接受超声辅助CDT,1643例(79.8%)接受单纯CDT;两组出血事件、血管升压药使用和机械通气率相似。校正后,超声辅助CDT与单纯CDT的院内死亡(OR 1.19;95%CI 0.63-2.26;P=0.59)和30天再入院(OR 0.75;95%CI 0.47-1.22;P=0.25)无显著差异。
要点
- 急性肺栓塞溶栓住院患者中全身溶栓占62.1%(3376/5436),CDT占37.9%(2060/5436)。
- 全身溶栓较CDT更多用于休克(15.8% vs 6.9%)、心脏骤停(12.7% vs 3.4%)、机械通气(19.0% vs 5.9%)和血管升压药使用(4.3% vs 1.0%)比例更高的患者。
- CDT患者中超声辅助CDT占20.2%(417/2060),单纯CDT占79.8%(1643/2060)。
- 超声辅助CDT与单纯CDT的出血事件、血管升压药使用和机械通气率相似。
- 校正后超声辅助CDT与单纯CDT的院内死亡(OR 1.19;95%CI 0.63-2.26;P=0.59)和30天再入院(OR 0.75;95%CI 0.47-1.22;P=0.25)无显著差异。
适用人群与场景
- 2016年全国再入院数据库中年龄>18岁、因急性肺栓塞住院并接受溶栓治疗的成人。
研究设计与关键结果
- 研究类型为全国性队列研究,样本量5436例住院,数据来自2016年全国再入院数据库,人群为年龄>18岁急性肺栓塞溶栓住院成人。
- 全身溶栓使用3376例(62.1%),CDT使用2060例(37.9%)。
- 全身溶栓组与CDT组比较:血管升压药使用4.3% vs 1.0%,休克15.8% vs 6.9%,心脏骤停12.7% vs 3.4%,机械通气19.0% vs 5.9%。
- CDT患者中超声辅助CDT 417例(20.2%),单纯CDT 1643例(79.8%)。
- 超声辅助CDT与单纯CDT的出血事件、血管升压药使用和机械通气率相似。
- 主要终点:校正后院内死亡OR 1.19(95%CI 0.63-2.26;P=0.59),30天再入院OR 0.75(95%CI 0.47-1.22;P=0.25),超声辅助CDT与单纯CDT之间无显著差异。
证据类型、等级与局限
- 证据类型:全国性队列研究(基于2016年全国再入院数据库)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: There are increased options to deliver thrombolytic treatment for acute, high-risk pulmonary embolism (PE). The goals of this study were to examine practice patterns of systemic thrombolysis and catheter-directed thrombolysis (CDT) and to compare outcomes following CDT with ultrasound facilitation (CDT-ultrasound) and CDT alone.
METHODS: The study analyzed adults aged > 18 years with hospitalizations associated with acute PE and thrombolysis in the 2016 Nationwide Readmissions Database. The study identified characteristics associated with the use of systemic thrombolysis and CDT. Comparisons of CDT-ultrasound vs CDT alone were then made by evaluating in-hospital events and readmissions. The primary outcomes were in-hospital mortality and 30-day readmission rates.
RESULTS: Among 5,436 hospitalizations, systemic thrombolysis was used more often (n = 3,376; 62.1%) than CDT (n = 2,060; 37.9%). Compared with CDT, systemic thrombolysis was used more frequently in patients with higher rates of vasopressor use (4.3% vs 1.0%), shock (15.8% vs. 6.9%), cardiac arrest (12.7% vs 3.4%), and mechanical ventilation (19.0% vs 5.9%). Among patients who underwent CDT, 417 (20.2%) received CDT-ultrasound, and 1,643 (79.8%) received CDT alone. Rates of bleeding events, vasopressor use, and mechanical ventilation were similar between therapeutic strategies. Following adjustment, in-hospital mortality (OR, 1.19; 95% CI, 0.63-2.26; P = .59) and 30-day readmission rates (OR, 0.75; 95% CI, 0.47-1.22; P = .25) were not significantly different between CDT-ultrasound and CDT alone.
CONCLUSIONS: Systemic thrombolysis is used more often than CDT in patients with acute PE, in particular among those with a greater prevalence of high-risk features. Among patients treated with CDT, there were no differences in events between CDT-ultrasound and CDT alone.
参考来源
- Beyer SE, Shanafelt C, Pinto DS, et al. Utilization and Outcomes of Thrombolytic Therapy for Acute Pulmonary Embolism: A Nationwide Cohort Study. Chest. 2019. PMID: 31783016. doi:10.1016/j.chest.2019.10.049
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。